Ana Pozueta-Cantudo
Overview
Explore the profile of Ana Pozueta-Cantudo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
17
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Martinez-Dubarbie F, Guerra-Ruiz A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, Pozueta-Cantudo A, et al.
Alzheimers Res Ther
. 2024 Dec;
16(1):268.
PMID: 39702464
Background: The advent of Alzheimer's disease-modifying drugs requires accurate biological diagnosis to identify candidates for these therapies. So far, the most promising single plasma biomarker is phosphorylated tau at threonine...
2.
Garcia-Martinez M, Pozueta-Cantudo A, Lage C, Martinez-Dubarbie F, Lopez-Garcia S, Fernandez-Matarrubia M, et al.
J Alzheimers Dis
. 2024 Jun;
100(3):1039-1053.
PMID: 38943389
Background: With the arrival of disease-modifying treatments, it is mandatory to find new cognitive markers that are sensitive to Alzheimer's disease (AD) pathology in preclinical stages. Objective: To determine the...
3.
Martinez-Dubarbie F, Lopez-Garcia S, Lage C, Di Molfetta G, Fernandez-Matarrubia M, Pozueta-Cantudo A, et al.
J Alzheimers Dis
. 2024 Mar;
98(3):1029-1042.
PMID: 38489191
Background: Plasma biomarkers of Alzheimer's disease (AD) constitute a non-invasive tool for diagnosing and classifying subjects. They change even in preclinical stages, but it is necessary to understand their properties...
4.
Martinez-Dubarbie F, Guerra-Ruiz A, Lopez-Garcia S, Irure-Ventura J, Lage C, Fernandez-Matarrubia M, et al.
Int J Mol Sci
. 2024 Feb;
25(3).
PMID: 38338759
Plasma biomarkers for Alzheimer's disease (AD) are a promising tool that may help in early diagnosis. However, their levels may be influenced by physiological parameters and comorbidities that should be...
5.
Martinez-Dubarbie F, Lobo D, Rollan-Martinez-Herrera M, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, et al.
Neurol Sci
. 2023 Nov;
45(4):1811.
PMID: 37910324
No abstract available.
6.
Martinez-Dubarbie F, Lobo D, Rollan-Martinez-Herrera M, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, et al.
Neurol Sci
. 2023 Oct;
45(4):1471-1480.
PMID: 37864751
Introduction: As Hearing loss and dementia affect people with the same profile, several epidemiological studies have evaluated their relationship. However, the link between age-related hearing loss and Alzheimer's disease is...
7.
Martinez-Dubarbie F, Guerra-Ruiz A, Lopez-Garcia S, Lage C, Fernandez-Matarrubia M, Infante J, et al.
Alzheimers Res Ther
. 2023 Oct;
15(1):163.
PMID: 37784138
Background: The arrival of new disease-modifying treatments for Alzheimer's disease (AD) requires the identification of subjects at risk in a simple, inexpensive, and non-invasive way. With tools allowing an adequate...